Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-042655
Filing Date
2021-08-09
Accepted
2021-08-09 16:17:45
Documents
73
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ttoo-10q_20210630.htm   iXBRL 10-Q 2305593
2 EX-31.1 ttoo-ex311_8.htm EX-31.1 16321
3 EX-31.2 ttoo-ex312_11.htm EX-31.2 16367
4 EX-32.1 ttoo-ex321_10.htm EX-32.1 5712
5 EX-32.2 ttoo-ex322_7.htm EX-32.2 5851
  Complete submission text file 0001564590-21-042655.txt   9223476

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA ttoo-20210630.xsd EX-101.SCH 59085
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ttoo-20210630_cal.xml EX-101.CAL 53130
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ttoo-20210630_def.xml EX-101.DEF 250450
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ttoo-20210630_lab.xml EX-101.LAB 507679
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ttoo-20210630_pre.xml EX-101.PRE 389146
11 EXTRACTED XBRL INSTANCE DOCUMENT ttoo-10q_20210630_htm.xml XML 1863579
Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Filer) CIK: 0001492674 (see all company filings)

EIN.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36571 | Film No.: 211156727
SIC: 3841 Surgical & Medical Instruments & Apparatus